We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 0DMW market cap is 335.67M. The company's latest EPS is RON 0.1202 and P/E is 4.16.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Revenue | 417.72M | 362.68M | 384.96M | 494.99M | 615.86M |
| Operating Income | 70.59M | 37.42M | 34.26M | 61.8M | 115.36M |
| Net Income | 30.82M | 26.39M | 29.94M | 38.51M | 80.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Assets | 794.02M | 863M | 895.39M | 856.47M | 1.13B |
| Total Liabilities | 297.17M | 285.73M | 290.4M | 215.04M | 281.5M |
| Total Equity | 496.84M | 577.27M | 604.99M | 641.43M | 850.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Operating | 20.63M | 94.05M | 44.44M | 105.56M | N/A |
| Investing | -69.18M | -47.99M | -29.05M | -39.88M | N/A |
| Financing | 23.45M | -1.86M | -8.42M | -12.61M | N/A |
| Market Cap | 335.67M |
| Price to Earnings Ratio | 4.16 |
| Price to Sales Ratio | 0.55 |
| Price to Cash Ratio | 185.19 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 671.34M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Antibiotice Sa |
| Address |
no 1, valea lupului street iasi 707410 |
| Website | https://www.antibiotice.ro |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
